EssilorLuxottica (ESLOY) and MidEuropa announced that they entered into an agreement for EssilorLuxottica to acquire Optegra, an ophthalmology platform operating in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands. The Optegra group, under the Optegra, Lexum and Iris brands, operates an extensive network of over 70 eye hospitals and diagnostic facilities across Europe, offering medically necessary ophthalmic treatments and elective vision correction procedures supported by AI in pre- and post-op stages. “With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform,” commented Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica. The transaction is expected to close later in 2025 pending regulatory approvals and other customary closing conditions.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESLOY:
- EssilorLuxottica price target lowered to EUR 290 from EUR 300 at Morgan Stanley
- EssilorLuxottica SA: Hold Rating Amid Sales Growth Challenges and Strategic Opportunities
- EssilorLuxottica reports Q1 revenue EUR 6.85B, up 7.3% at CER
- EssilorLuxottica price target lowered to EUR 270 from EUR 280 at JPMorgan
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue